Business Description
Hayat Pharmaceutical Industries Co
ISIN : JO4121011012
Compare
Compare
Traded in other countries / regions
HPIC.Jordan IPO Date
2006-05-01Description
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. Its principal activity is producing human and veterinary in all its forms and medical stickers and stockings. The company is also involved in the production of medical supplies, body care lotions, cosmetics and initiating marketing campaigns as well as import and export operations. It has developed and registered hundred sixteen different dosage forms/pack sizes in the Jordan market representing fifty six different brands (molecules) in various therapeutic areas. Its products include Cardiovascular system, Infectious disease Dermatology, Gastrointestinal system, and Respiratory system.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.93 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | 2.01 | |||||
| Interest Coverage | 4.77 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.76 | |||||
| Beneish M-Score | -1.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -5.3 | |||||
| 3-Year EPS without NRI Growth Rate | -12.3 | |||||
| 3-Year FCF Growth Rate | -8.4 | |||||
| 3-Year Book Growth Rate | 3.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.41 | |||||
| 9-Day RSI | 54.52 | |||||
| 14-Day RSI | 50.2 | |||||
| 6-1 Month Momentum % | 4.49 | |||||
| 12-1 Month Momentum % | -16.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.79 | |||||
| Quick Ratio | 3.75 | |||||
| Cash Ratio | 1.28 | |||||
| Days Inventory | 585.98 | |||||
| Days Sales Outstanding | 408.91 | |||||
| Days Payable | 215.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 6.57 | |||||
| Dividend Payout Ratio | 6.94 | |||||
| 3-Year Dividend Growth Rate | 35.7 | |||||
| Forward Dividend Yield % | 6.57 | |||||
| 5-Year Yield-on-Cost % | 18.5 | |||||
| Shareholder Yield % | 3.58 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.44 | |||||
| Operating Margin % | 4.17 | |||||
| Net Margin % | 7.05 | |||||
| FCF Margin % | -5.89 | |||||
| ROE % | 1.31 | |||||
| ROA % | 1.1 | |||||
| ROIC % | 0.77 | |||||
| ROC (Joel Greenblatt) % | 2.37 | |||||
| ROCE % | 1.58 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 69.72 | |||||
| PE Ratio without NRI | 69.72 | |||||
| Shiller PE Ratio | 6.84 | |||||
| PEG Ratio | 43.58 | |||||
| PS Ratio | 4.43 | |||||
| PB Ratio | 0.8 | |||||
| Price-to-Tangible-Book | 0.81 | |||||
| EV-to-EBIT | 41.69 | |||||
| EV-to-EBITDA | 19.19 | |||||
| EV-to-Revenue | 3.69 | |||||
| EV-to-FCF | -62.6 | |||||
| Price-to-Projected-FCF | 0.57 | |||||
| Price-to-Median-PS-Value | 2.61 | |||||
| Price-to-Graham-Number | 1.27 | |||||
| Price-to-Net-Current-Asset-Value | 1.43 | |||||
| Earnings Yield (Greenblatt) % | 2.4 | |||||
| FCF Yield % | -1.33 | |||||
| Forward Rate of Return (Yacktman) % | -4.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hayat Pharmaceutical Industries Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil JOD) | 5.378 | ||
| EPS (TTM) (JOD) | 0.036 | ||
| Beta | 0 | ||
| Volatility % | 25.33 | ||
| 14-Day RSI | 50.2 | ||
| 14-Day ATR (JOD) | 0.014483 | ||
| 20-Day SMA (JOD) | 2.508 | ||
| 12-1 Month Momentum % | -16.88 | ||
| 52-Week Range (JOD) | 2.4 - 3.2 | ||
| Shares Outstanding (Mil) | 9.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hayat Pharmaceutical Industries Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hayat Pharmaceutical Industries Co Stock Events
| Event | Date | Price(JOD) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hayat Pharmaceutical Industries Co Frequently Asked Questions
What is Hayat Pharmaceutical Industries Co(AMM:HPIC)'s stock price today?
The current price of AMM:HPIC is JOD2.51. The 52 week high of AMM:HPIC is JOD3.20 and 52 week low is JOD2.40.
When is next earnings date of Hayat Pharmaceutical Industries Co(AMM:HPIC)?
The next earnings date of Hayat Pharmaceutical Industries Co(AMM:HPIC) is .
Does Hayat Pharmaceutical Industries Co(AMM:HPIC) pay dividends? If so, how much?
The Dividend Yield %  of Hayat Pharmaceutical Industries Co(AMM:HPIC) is 6.57% (As of Today), Highest Dividend Payout Ratio of Hayat Pharmaceutical Industries Co(AMM:HPIC) was 6.94. The lowest was 0.27. And the median was 0.42. The  Forward Dividend Yield % of Hayat Pharmaceutical Industries Co(AMM:HPIC) is 6.57%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers